🇺🇸 FDA
Pipeline program

Povorcitinib, Povorcitinib, Povorcitinib

INCB054707-801

Phase 3 small_molecule active

Quick answer

Povorcitinib, Povorcitinib, Povorcitinib for Hidradenitis Suppurativa // Prurigo Nodularis // Vitiligo is a Phase 3 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Incyte Biosciences Distribution B.V.
Indication
Hidradenitis Suppurativa // Prurigo Nodularis // Vitiligo
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials